J. Scherer

发表

The impact of familial loading on gender differences in age at onset of schizophrenia

M. Albus, J. Scherer, S. Hueber, 1994, Acta psychiatrica Scandinavica.

Iodine-123-iodobenzamide SPECT assessment of dopamine D2 receptor occupancy in riperidone-treated schizophrenic patients.

K. Hahn, K. Tatsch, S. Dresel, 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Panic disorder with or without concomitant depression 5 years after treatment: a prospective follow-up.

M. Albus, J. Scherer, G. Scheibe, 1995, Journal of affective disorders.

D2‐dopamine receptor occupancy differs between patients with and without extrapyramidal side effects

M. Albus, K. Tatsch, J. Schwarz, 1994, Acta psychiatrica Scandinavica.

Consistency of assessment of adverse drug reactions in psychiatric hospitals: A comparison of an algorithmic and an empirical approach

R. Grohmann, J. Scherer, B. Müller-Oerlinghausen, 2004, European Journal of Clinical Pharmacology.

Therapy monitoring

C. Kirsch, K. Tatsch, J. Schwarz, 2006, Journal of Neurology.

D2-dopamine-receptor occupancy during treatment with haloperidol decanoate

W. Oertel, M. Albus, K. Tatsch, 2008, European Archives of Psychiatry and Clinical Neuroscience.

[High dose L-thyroxine in therapy refractory depression. Case analysis and catamnesis as quality control].

M. Albus, J. Scherer, H. Pfeiffer, 2004, Der Nervenarzt.

Neurological soft signs and neuropsychological performance in patients with first episode schizophrenia

M. Albus, J. Scherer, F. Mohr, 2003, Psychiatry Research.

Age at onset anticipation in familial schizophrenia. Does the phenomenon even exist?

M. Albus, J. Scherer, M. Borrmann-Hassenbach, 1999, Schizophrenia Research.

Reduced striatal dopaminergic innervation shown by IPT and SPECT in patients under neuroleptic treatment: need for levodopa therapy?

C. Trenkwalder, K. Tatsch, J. Schwarz, 1998, Psychiatry Research: Neuroimaging.

Assessment of adverse drug reactions in psychiatric hospitals

E. Rüther, H. Hippius, R. Grohmann, 2004, European Journal of Clinical Pharmacology.

Methodological Problems in Assessment of Adverse Drug Reactions with Drug Combinations

R. Grohmann, J. Scherer, P. Dirschedl, 1986 .

A prospective 2-year follow-up study of neurocognitive functioning in patients with first-episode schizophrenia

M. Albus, J. Scherer, F. Mohr, 2002, European Archives of Psychiatry and Clinical Neuroscience.

Neuropsychological impairment and psychopathology in first-episode schizophrenic patients related to the early course of illness

M. Albus, J. Scherer, F. Mohr, 1998, European Archives of Psychiatry and Clinical Neuroscience.

Are there gender differences in neuropsychological performance in patients with first-episode schizophrenia?

M. Albus, J. Scherer, F. Mohr, 1997, Schizophrenia Research.

Adverse drug reactions

W. Poser, R. Grohmann, J. Scherer, 1984 .

[Which factors modify drug-compliance?].

M. Albus, J. Scherer, S. Burkes, 1995, Psychiatrische Praxis.

Decrease of D2 receptors indicated by 123I‐iodobenzamide single‐photon emission computed tomography relates to neurological deficit in treated Wilson's disease

T. Vogl, E. Kraft, C. Kirsch, 1992, Annals of neurology.

Reliability of adverse drug reaction assessment in psychiatric inpatients

R. Grohmann, J. Scherer, L. Schmidt, 2004, European archives of psychiatry and neurological sciences.

Reliability of Adverse Drug Reaction Assessment in Psychiatric Inpatients

R. Grohmann, J. Scherer, P. Dirschedl, 1986, Drug information journal.

Acute Delirious Syndromes due to Psychotropic Drugs

E. Rüther, R. Grohmann, J. Scherer, 1986 .

The Importance of the Quantitative Description of Drug Therapy for Drug Surveillance in Psychiatry

E. Rüther, F. Friedl, J. Scherer, 1985 .

Schizophrenia, neurobiology and the methodology of systemic modeling.

F. Tretter, J. Scherer, 2006, Pharmacopsychiatry.

Striatal D2-dopamine receptor occupancy during treatment with typical and atypical neuroleptics

W. Oertel, M. Albus, K. Tatsch, 1994, Biological Psychiatry.

Schizophrenia, neurobiology and the methodology of systemic modeling.

F. Tretter, J. Scherer, 2006, Pharmacopsychiatry.

Haloperidol Plasma Level after a Test Dose as Predictor for the Clinical Response to Treatment in Acute Schizophrenic Patients

E. Rüther, J. Scherer, F. Müller-Spahn, 1988, Pharmacopsychiatry.

L-Thyroxin-Hochdosierung bei therapieresistenter Depression

M. Albus, J. Scherer, Dr. H. Pfeiffer, 2003, Der Nervenarzt.

[Neuropsychological deficits in the initial acute episode of schizophrenia. A comparison with chronic schizophrenic patients].

M. Albus, J. Scherer, F. Mohr, 1999, Der Nervenarzt.

Receptor Imaging of Schizophrenic Patients under Treatment with Typical and Atypical Neuroleptics

E. Meisenzahl, K. Tatsch, S. Dresel, 2022 .

P.1.094 Week two HAMD score predicts onset of action of TCA

M. Albus, J. Scherer, H. Pfeiffer, 1997, European Neuropsychopharmacology.